CSIMarket
 
Stryker Corp  (NYSE: SYK)
 
Price: $269.5350 $-0.48 -0.176%
Day's High: $271.59759521484375 Week Perf: -11.08 %
Day's Low: $ 267.36 30 Day Perf: -22.37 %
Volume (M): 849,911 52 Wk High: $ 392.55
Volume (M$): $ 0 52 Wk Avg: $343.20
Open: $270.72 52 Wk Low: $267.36



 Market Capitalization (Millions $) 104,041
 Shares Outstanding (Millions) 386
 Employees 56,000
 Revenues (TTM) (Millions $) 25,837
 Net Income (TTM) (Millions $) 3,729
 Cash Flow (TTM) (Millions $) 503
 Capital Exp. (TTM) (Millions $) 823

Business Description


Company Profile: Stryker Corporation

Overview:
Stryker Corporation is a leading global medical device company, renowned for its innovative products and solutions in the orthopaedic market. Founded in 1946 in Michigan as a successor to a business established by Dr. Homer H. Stryker, a pioneering orthopaedic surgeon, the company has since evolved into one of the largest and most respected entities in the medical field.

Core Competencies:
Stryker specializes in a comprehensive array of medical devices and technologies, which include:

- Orthopaedic Products: Joint replacements, trauma devices, spinal systems, and micro-implant technologies.
- Orthobiologics: Innovative solutions to enhance healing practices and improve outcomes for patients undergoing surgery.
- Surgical Instruments: Advanced powered surgical instruments and navigation systems that enhance the precision and efficiency of surgical procedures.
- Endoscopic Products: Tools and devices designed for minimally invasive surgeries that improve patient recovery times and surgical outcomes.
- Emergency Medical Equipment: A range of patient handling solutions, including stretchers and transport devices, designed for emergency medical services.
- Outpatient Physical Therapy: Stryker also offers outpatient physical therapy services across the United States, focusing on recovery and rehabilitation.

Mission and Vision:
Stryker is committed to advancing healthcare by providing innovative products and services that meet the needs of healthcare professionals and their patients. The company aims to enhance patient care through continuous innovation and excellence in the design and manufacturing of medical devices.

Global Presence:
Operating in multiple countries around the world, Stryker Corporation leverages its expansive distribution network to reach a wide variety of healthcare settings, from hospitals to outpatient facilities.

Recent Developments:
Stryker remains at the forefront of medical technology, continually investing in research and development to bring cutting-edge solutions and products to market. The companys strong emphasis on innovation and quality has solidified its reputation as a trusted partner in the healthcare industry.

Commitment to Sustainability:
Stryker is dedicated to sustainability and corporate responsibility, focusing on minimizing its environmental impact and contributing positively to the communities it serves.

With a robust portfolio and a strong foundation built on a legacy of innovation, Stryker Corporation is well-positioned to lead the medical device industry into the future.


   Company Address: 1941 Stryker Way Portage, 49002 MI
   Company Phone Number: 385-2600   Stock Exchange / Ticker: NYSE SYK


Customers Net Income grew by SYK's Customers Net Profit Margin grew to

12.84 %

10.98 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BDX   -6.1%    
EW   -5.11%    
ISRG   -0.38%    
MDT   -2.35%    
TFX   -7.75%    
ZBH   -6.52%    
• View Complete Report
   



Dividend

Strykers Dividend Boost Fortifies Shareholder Confidence Amid Continued Stock Surge,

Published Wed, Feb 5 2025 1:01 PM UTC

Stryker s Steady Dividend Growth Signals Confidence Amid Market MomentumIn a strategic move that underscores its commitment to shareholder returns, Stryker Corporation (NYSE: SYK) announced a quarterly dividend of $0.84 per share, payable on April 30, 2025. The decision came from the company’s Board of Directors and reflects a 5% increase compared to the same period last y...

Management Changes

Stryker Corporation Announces CFO Transition as Glenn Boehnlein Retires After 22 Years,

Published Tue, Jan 28 2025 9:05 PM UTC

Stryker Corp Announces Leadership Transition as CFO Glenn Boehnlein Retires After 22 YearsStryker Corporation (NYSE: SYK) is set to embark on a new chapter as the company announces the retirement of Glenn S. Boehnlein from his role as Vice President and Chief Financial Officer (CFO). This significant leadership transition comes after an impressive 22-year tenure, during whic...

Announcement

Strykers Stride Balancing Revenue Gains with Economic Realities,

Published Mon, Jan 6 2025 1:39 PM UTC

Stryker s Financial Horizon: Navigating Robust Revenues and Rising Costs Stryker Corporation (NYSE: SYK), a prominent player in the medical technology sector, is gearing up to announce its financial results for the fourth quarter and full year 2024 on January 28, 2025. Ahead of the anticipated report, a detailed look at the company s annual performance reveals a landscape o...

Announcement

Stryker Corporation Prepares for Financial Transparency Third Quarter and Second Quarter Results Announced

Published Tue, Oct 1 2024 8:00 PM UTC

In the ever-evolving landscape of the healthcare industry, Stryker Corporation continues to establish itself as a leader, showing remarkable resilience and commitment to financial accountability. Based in Portage, Michigan, Stryker (NYSE:SYK) is set to unveil its third quarter financial results for fiscal year 2024 on October 29, 2024. This announcement aligns perfectly with...

Merger and Acquisition

Strykers Strategic Expansion: The Acquisition of Vertos Medical to Revolutionize Pain Management Solutions

Published Tue, Oct 1 2024 12:00 PM UTC

In a significant move to strengthen its foothold in the interventional pain management sector, Stryker Corporation (NYSE: SYK) announced the completion of its acquisition of Vertos Medical, Inc. on October 1, 2024. This acquisition marks a pivotal expansion for Stryker, a company renowned for its commitment to innovation in medical technologies and devices. With a special fo...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 27.93
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 4.03
Price to Sales (Expected) -
Price to Book 4.34
PEG (TTM) 1.01

Financial Strength Current
Quick Ratio 0.52
Working Capital Ratio 2.16
Leverage Ratio (MRQ) 1
Total Debt to Equity 0.65
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.42

Per Share Current
Earnings (TTM) 9.65 $
Revenues (TTM) 66.94 $
Cash Flow (TTM) 1.3 $
Cash 9.09 $
Book Value 62.15 $
Dividend (TTM) 3.48 $

Efficiency Current
Revenue per Employee (TTM) 461,375
Net Income per Employee (TTM) 66,589
Receivable Turnover Ratio (TTM) 6.89
Inventory Turnover Ratio (TTM) 1.67
Asset Turnover Ratio (TTM) 0.54

Profitability Ratios Current
Gross Margin (MRQ) 68.27 %
Operating Margin (MRQ) 25.18 %
Net Margin (MRQ) 19.37 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 27.56 %

Management Effectiveness Current
Return On Assets (TTM) 7.85 %
Return On Investment (TTM) 8.8 %
Return On Equity (TTM) 16.36 %
Dividend Yield 1.31 %
Pay out Ratio (TTM) 36.06 %



Stryker's Segments
Orthopaedic Instruments    8.12 % of total Revenue
Other Orthopedics    2.61 % of total Revenue
Neuro Cranial Instruments    10.07 % of total Revenue
Enabling Technologies    0.43 % of total Revenue
United States    74.35 % of total Revenue
International    25.65 % of total Revenue
MedSurg and Neurotechnology    53.27 % of total Revenue
MedSurg and Neurotechnology United States    41.43 % of total Revenue
MedSurg and Neurotechnology International    11.84 % of total Revenue
MedSurg and Neurotechnology Instruments    15.28 % of total Revenue
MedSurg and Neurotechnology Instruments United States    12.72 % of total Revenue
MedSurg and Neurotechnology Instruments International    2.56 % of total Revenue
MedSurg and Neurotechnology Endoscopy    14.42 % of total Revenue
MedSurg and Neurotechnology Endoscopy United States    11.64 % of total Revenue
MedSurg and Neurotechnology Endoscopy International    2.77 % of total Revenue
MedSurg and Neurotechnology Medical    14.98 % of total Revenue
MedSurg and Neurotechnology Medical United States    12.41 % of total Revenue
MedSurg and Neurotechnology Medical International    2.57 % of total Revenue
MedSurg and Neurotechnology Vascular    8.59 % of total Revenue
MedSurg and Neurotechnology Vascular United States    4.65 % of total Revenue
MedSurg and Neurotechnology Vascular International    3.94 % of total Revenue
Orthopaedics    46.73 % of total Revenue
Orthopaedics United States    32.92 % of total Revenue
Orthopaedics International    13.8 % of total Revenue
Orthopaedics Knees    11.13 % of total Revenue
Orthopaedics Knees United States    7.84 % of total Revenue
Orthopaedics Knees International    3.29 % of total Revenue
Orthopaedics Hips    7.64 % of total Revenue
Orthopaedics Hips United States    4.58 % of total Revenue
Orthopaedics Hips International    3.06 % of total Revenue
Orthopaedics Trauma and Extremities    17.19 % of total Revenue
Orthopaedics Trauma and Extremities United States    12.74 % of total Revenue
Orthopaedics Trauma and Extremities International    4.45 % of total Revenue
Orthopaedics Ortho Tech    10.73 % of total Revenue
Orthopaedics Ortho Tech United States    7.76 % of total Revenue
Orthopaedics Ortho Tech International    2.97 % of total Revenue
Orthopaedics Spinal Implants    0.03 % of total Revenue
Orthopaedics Spinal Implants International    0.03 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.